Results for “ ”

Entry Author Date Location
Cytokinetics Pivots to Another ALS Drug After Phase 3 Failure 11/21/17 San Francisco
Ed Kaye on Sarepta’s Duchenne Quest, Rising to CEO & His New Startup 11/20/17 Boston
Bio Roundup: ICER Eyes Cost, Azar at HHS, Gates’s ALZ Cash & More 11/17/17 National
Healthcare + A.I. in Boston: The Photos 11/16/17 Boston
At Seattle Children’s, Another Piece of Ambitious CAR-T Plan in Place 11/16/17 Seattle
X4 Pharma Pulls In $27M for Immune Drug in Cancer, Rare Diseases 11/16/17 Boston
Inozyme Gets $49M From Sanofi, Novo to Tackle Rare Infant Disease 11/15/17 Boston
ImmusanT Gets $40M From Arch, Vatera to Continue Celiac Vaccine Quest 11/14/17 Boston
In a Precision Step, Bayer Writes Loxo $400M Check for Two Cancer Drugs 11/14/17 New York
With $25M, Torque Aims for a More Targeted Cell Therapy for Cancer 11/14/17 Boston
Juno Dissects ROCKET Deaths, Will Aim Better CAR-T at Leukemia 11/10/17 Seattle
Bio Roundup: Barron Joins GSK, Sage Bounces Back, Valeant Dumps Addyi 11/10/17 National
Sage Bounces Back, Eyes FDA Filing for Postpartum Drug 11/09/17 Boston
Microsoft’s Strategy for Finding What’s Next in Healthcare A.I. 11/08/17 Seattle
With $40M for Exonics, Duchenne’s Gene Therapy, CRISPR Race Heats Up 11/08/17 Boston
Xconomy Newcomer Award Winner Amy Schulman on Boston Biotech Life 11/06/17 Boston
Biotech Roundup: Opioid News, ASH Preview, Boston Bio IPOs & More 11/03/17 National
Spero, Allena Nab $152M As Bio IPOs, With Insider Help, Continue Roll 11/02/17 Boston
Few Opioid Alternatives In Sight as Crisis Gains Political Attention 11/01/17 National
ASH Sneak Peeks: Novartis, Juno Update CAR-T Lymphoma Competition 11/01/17 National
Sanofi Pulls Back from Voyager Gene Therapy Pact in Parkinson’s 10/31/17 Boston
New Survey Highlights “Lethargic Pace” of Healthcare Gender Equity 10/31/17 National
Q&A: Xconomy Award Winner Nikhil Wagle on Building Patient Partnerships 10/30/17 Boston
Bio Roundup: CBO’s Praise, Celgene’s Shock, Trump’s Opioid Plan & More 10/27/17 National
CRISPR Pioneer Zhang Details New Editing System Downstream From DNA 10/25/17 Boston
As Drugs Fail, Some Researchers Urge a Return to Alzheimer’s Roots 10/25/17 National
DOTS Technology Pulls in $20M for Rapid Food Allergen Detector 10/23/17 Boston
Arsanis Eyes IPO to Support Clinical Testing of Pneumonia Drug 10/23/17 Boston
Xconomy Q&A: An Update with Arcturus Therapeutics CEO Joseph Payne 10/23/17 San Diego
Devoted Health, Led by Athenahealth Alums Ed & Todd Park, Bags $62M 10/23/17 Boston
Page 1 of 130 next page »